Helius Medical Technologies Inc (HMT) is a medical device company. It provides neurological wellness solutions. The company development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides the development of technologies as a potential treatment for neurological symptoms caused by disease or trauma. HMT provides a portable neuromodulation stimulator (PoNS) device, an investigational device in development, that enables physicians and patients to manage a host of neurological symptoms. The company offers devices that use results from the planned pivotal, multi-center mTBI study to support an application to the FDA for commercial distribution. HMT is headquartered in Newtown, Pennsylvania, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Helius Medical Technologies Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Helius Medical Technologies Inc Company Overview
Helius Medical Technologies Inc Company Snapshot
Helius Medical Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Helius Medical Technologies Inc – Pipeline Analysis Overview
Helius Medical Technologies Inc - Key Facts
Helius Medical Technologies Inc - Major Products and Services
Helius Medical Technologies Inc Pipeline Products by Development Stage
Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
Helius Medical Technologies Inc Pipeline Products Overview
Helius Medical Technologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Helius Medical Technologies Inc, Recent Developments
Sep 13, 2023: Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference
Aug 02, 2023: Helius Medical Technologies to Release Second Quarter 2023 Financial Results on August 10, 2023
Mar 09, 2023: Helius Medical Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 06, 2023: Helius Medical Technologies to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
Nov 14, 2022: Helius Medical Technologies Reports Third Quarter 2022 Financial Results
Nov 09, 2022: Helius Medical Technologies, announces participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program
Sep 29, 2022: Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference
Aug 15, 2022: Helius Medical Technologies Reports Second Quarter 2022 Financial Results
May 12, 2022: Helius Medical Technologies Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®
Mar 14, 2022: Helius Medical Technologies Reports Fourth Quarter and Full Year 2021 Financial Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Helius Medical Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Helius Medical Technologies Inc Pipeline Products by Equipment Type
Table 3: Helius Medical Technologies Inc Pipeline Products by Indication
Table 4: Helius Medical Technologies Inc, Key Facts
Table 5: Helius Medical Technologies Inc, Major Products and Services
Table 6: Helius Medical Technologies Inc Number of Pipeline Products by Development Stage
Table 7: Helius Medical Technologies Inc Pipeline Products Summary by Development Stage
Table 8: Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
Table 9: Helius Medical Technologies Inc Ongoing Clinical Trials Summary
Table 10: PoNS Device - Cerebral Palsy - Product Status